Evolution in Thoracic Oncology: Genomics and Treatment for Early Stage NSCLC David H. Harpole, Jr., M.D. Professor of Surgery Associate Professor of Pathology.
Gene Expression Signatures for Prognosis in NSCLC, Coupled with Signatures of Oncogenic Pathway Deregulation, Provide a Novel Approach for Selection of.
David H. Harpole, Jr., M.D. Professor of Surgery Duke University Medical Center
